New Avalere research finds that health plan members enrolled in plans that cover abuse-deterrent for...
“Deeply rooted in our clients' business, we identify relevant data analyses to work together to determine effective solutions.”
Senior Vice President
Infusing Big Data with Expert Insights
Our robust proprietary data assets–the MORE2 Registry® and CMS Qualified Entity (QE) data–strengthen our methods by leveraging information from 40.1 billion medical events and 261 million unique patients. With in-house experts spanning economics, actuarial science, policy, market access and reimbursement, payment and delivery, and value-based care, we answer complex questions supported by patient data. Our predictive modeling can help you determine how health reforms and payment policies will impact your business financials. Manufacturers count on our statistical techniques and benchmarking to support product commercialization. And Congress relies on our analysis to weigh policy decisions. Together, we can take your business to the next level with facts and expert interpretation and guidance.
Whether you are from a life sciences company, plan, or provider, we have you covered.
Budget Impact & Cost-Effective Modeling
Real-World Data-Driven Insights